financetom
STEP
financetom
/
Financials
/
STEP
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
StepStone Group Inc.STEP
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

StepStone Group LP. is an investment firm specializing in direct, fund of funds, secondary direct, and secondary indirect investments.

For direct investment, it seeks to invest in venture debt, incubation, mezzanine, distressed/vulture, seed/startup, early venture, mid venture, late venture, emerging growth, later stage, turnaround, growth capital, industry consolidation, recapitalization, private equity and buyout investments in mature and middle market companies.

It prefers to invest in natural resources, technology, healthcare, services, materials, manufacturing, consumer durables, apparel, hotels, restaurants and leisure, media, retailing, consumer staples, financials, telecommunication services, energy, infrastructure, real estate, and real asset.

The firm invests globally with a focus on United States, North America, Europe, Asia, Latin America, Middle East, Africa, Brazil, Mexico, Argentina, Colombia, New Zealand, China, India, Korea, Japan, Taiwan, and Australia region.

It typically invests between $15 million and $200 million in firms with enterprise value between $150 million and $25000 million.

The firm invests between 5% and 40% in emerging markets. For fund of fund investment, it seeks to invest in private equity funds, venture capital funds, Special situation funds, Real estate funds, Infrastructure funds, mezzanine funds, and turnaround/distressed funds.

It considers investments in both domestic and international funds. It also seeks to make co-investments and follow-on investments and considers partial interests in funds.

StepStone Group LP. was founded in 2007 and is based in New York, New York with additional offices across North America, South America, Europe, Australia, Asia, LA Jolla, California.

Latest News >
DISQO Releases New Product: Making Brand Lift Measurement Free and Accessible for All Media Companies
DISQO Releases New Product: Making Brand Lift Measurement Free and Accessible for All Media Companies
Sep 30, 2025
Los Angeles, California, Sept. 30, 2025 (GLOBE NEWSWIRE) -- DISQO, the most advanced platform for measuring how advertising works, today announced the launch of its free self-serve Brand Lift product for media companies. For the first time, publishers, DSPs, and retail media networks can measure brand outcomes on campaigns simply, at scale, and without cost barriers. While media companies are...
POET Technologies and Semtech Launch 1.6T Optical Receivers for AI Networks
POET Technologies and Semtech Launch 1.6T Optical Receivers for AI Networks
Sep 30, 2025
SAN JOSE, Calif. and CAMARILLO, Calif., Sept. 30, 2025 (GLOBE NEWSWIRE) -- POET Technologies Inc. ( POET ) , a leader in the design and implementation of highly-integrated optical engines and light sources for artificial intelligence networks, today announced with Semtech Corporation , a leading provider of high-performance semiconductor, Internet of Things (IoT) systems and cloud connectivity service solutions, the...
Market Chatter: UBS, Switzerland Consider Lower Capital Rules
Market Chatter: UBS, Switzerland Consider Lower Capital Rules
Sep 30, 2025
07:57 AM EDT, 09/30/2025 (MT Newswires) -- UBS (UBS) and Switzerland are privately open to a compromise on new capital rules, potentially clearing a path for lower requirements acceptable to both sides, Reuters reported Tuesday, citing people familiar with the situation. Bern could accept trimming the extra capital burden to $15 billion from the $24 billion plan from June, a...
P&C Labs Achieves Immediate Efficiency Gains with Proscia’s Software
P&C Labs Achieves Immediate Efficiency Gains with Proscia’s Software
Sep 30, 2025
LEXINGTON, Ky. and PHILADELPHIA, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Pathology & Cytology Laboratories (P&C Labs), a nationally recognized leader in pathology services, has partnered with Proscia®, a pathology AI company, to fully transform its operations. Within weeks of deploying Proscia’s Concentriq® software platform, the laboratory is already realizing meaningful results. One-day turnaround time (TAT) has increased by 88%, rising...
Copyright 2023-2025 - www.financetom.com All Rights Reserved